Literature DB >> 31196723

Long-term outcomes of enzyme replacement therapy for Taiwanese patients with Mucopolysaccharidosis I.

Hsiang-Yu Lin1, Chung-Lin Lee2, Chih-Kuang Chuang3, Shuan-Pei Lin4.   

Abstract

Entities:  

Year:  2019        PMID： 31196723     DOI： 10.1016/j.pedneo.2019.05.005

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN： 1875-9572            Impact factor:   2.083


× No keyword cloud information.
  3 in total

Review 1.  Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations.

Authors:  Rossella Parini; Federica Deodato
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

2.  An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan.

Authors:  Hsiang-Yu Lin; Chung-Lin Lee; Yun-Ting Lo; Ru-Yi Tu; Ya-Hui Chang; Chia-Ying Chang; Pao Chin Chiu; Tung-Ming Chang; Wen-Hui Tsai; Dau-Ming Niu; Chih-Kuang Chuang; Shuan-Pei Lin
Journal:  Diagnostics (Basel)       Date:  2019-10-05

3.  Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019).

Authors:  Hsiang-Yu Lin; Chung-Lin Lee; Chia-Ying Chang; Pao Chin Chiu; Yin-Hsiu Chien; Dau-Ming Niu; Fuu-Jen Tsai; Wuh-Liang Hwu; Shio Jean Lin; Ju-Li Lin; Mei-Chyn Chao; Tung-Ming Chang; Wen-Hui Tsai; Tzu-Jou Wang; Chih-Kuang Chuang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2020-11-07       Impact factor: 4.123
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.